



It’s true that I have
written on this topic
before but my
knowledge of the







the picture I received
of the NIH study sections was of
groups who had managed to combine
inanity with iniquity laced with
ignorance. As this came from people
who had been turned down by one or
other of these study sections I
thought there was a certain amount
of exaggeration but, now that I have
direct experience of the ‘NIH
system’, I can confirm that
everything I have been told is
absolutely true.
A few months ago, against my
better judgement, I applied for a
relatively small grant to support
some work on the pufferfish
genome that might have some
relevance to one of the many
diseases that NIH is determined to
cure. Also, against my better
judgement, I took the advice of a
semi-professional grant writer who
criticized one section, where I
simply stated that we would try an
experiment which had never been
done before. He insisted that I
provide an example of what might
be expected and, in fact, he found
one for me, assuring me that
without this, I could not expect to
be funded.
After several months I received a
notice that my priority had been
assigned as 272, which I was told
was dismal. Some weeks later I
received a bulky document called a
summary statement detailing the
proceedings and the result of the
peer review by the study section
and enclosing a list of the members
many of whose names were not
familiar to me. Roughly speaking,
they had come to the conclusion
that although I had done a few
things in the past I was out of my
depth in the particular area chosen
and although they admitted that I
had some scientific expertise they
felt that I should seek some help; all
of this had conspired to reduce me
to the 52.5 percentile rank.
In studying the document I
noticed that I was much worse than
that. Apparently, the section
members assign scores from 100 to
500 based on scientific merit. This
means you cannot do worse than 100,
and so there are only four intervals
and the midpoint is at 300, which
means that with a score of 272 I was
actually below the percentile rank
assigned to me. This sort of
arithmetic misunderstanding is
common among biological scientists.
Recently, at a meeting, a graph was
shown with four points to illustrate
the claim of a 104 dynamic range. As
there were only three intervals, and
the first point was close to the noise
level, the dynamic range was really
only about 500.
The document also provided me
with three critiques of my
application. One of these reviewers
was clearly inexperienced in the
language of critiques because he
actually praised the work with terms
such as “sound thinking”, “original
approach”, and so on. The third
reviewer was brief and said that as I
had not stated precisely what I
intended to do, he was not
convinced the experiments would
work and suspected the example I
provided was wrong.
It is the critique of the second
reviewer that needs more critical
attention. I had stated that as we are
more distant from fish than we are
from rodents, comparing fish genes
with their human counterparts was
better than comparing the human
with mouse genes. In other words,
the common ancestor of mice and
humans is so recent that we cannot
assume that similarities between
their genomes represent common
function. But in the case of fish and
humans, there has been sufficient
evolutionary time for mutations to
destroy the similarities that arise
simply out of a common origin. Now,
I thought this to be an unalterable
fact but I was told that “while
possibly true, it would seem that this
claim is premature at the moment,”
from which I can only conclude that
the reviewer does not understand
that evolution is irreversible.
Actually, it was quite easy to
deconstruct the critique, which must
have come from a member of the
Genome Politburo because he
produced that heavy old argument
that we will soon have the sequence
of both the human and mouse
genomes and we don’t need any of
this fish genome rubbish. He totally
missed the point of the research —
which was to try to find control
sequences —because he thought
that I should use cDNAs from
mouse or human genes. Anybody
could do that.
I have seen guidelines on what
such committees should look for in
applications suitable for acceptance,
and I now offer some convenient
guidelines for rejection. If it is novel
and nobody knows whether it will
work or not, call it “over ambitious
and superficial”; if it offers a better
way of approaching a problem,
protect all established plans by
calling it “unnecessary and
redundant”; and if you find that the
applicant has never done an
experiment on the 8th base of tRNA,
say he lacks the “necessary
experience to conduct these
notoriously difficult experiments”.
And turn it down.
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